Cargando…

Incidence of anterior uveitis in patients with axial spondyloarthritis treated with anti-TNF or anti-IL17A: a systematic review, a pairwise and network meta-analysis of randomized controlled trials

BACKGROUND: Anterior uveitis (AU) is the most frequent extra-articular feature of axial spondyloarthritis (axSpA). We aimed to assess and compare the incidence of AU in axSpA patients treated with anti-TNF or anti-IL17A. METHODS: We systematically reviewed PubMed, EMBase, and Cochrane from inception...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roche, Damien, Badard, Martin, Boyer, Laurent, Lafforgue, Pierre, Pham, Thao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283999/ https://www.ncbi.nlm.nih.gov/pubmed/34271991 http://dx.doi.org/10.1186/s13075-021-02549-0

Ejemplares similares

Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis
por: Atzeni, Fabiola, et al.
Publicado: (2021)

Anti-IL17A in Axial Spondyloarthritis—Where Are We At?
por: Cheung, Peter P.
Publicado: (2017)

O27 Recurrent severe uveitis treated with secukinumab following anti-TNF induced cutaneous vasculitis in a patient with axial spondyloarthritis
por: Chan, Antoni, et al.
Publicado: (2021)

Innate Cells: The Alternative Source of IL-17 in Axial and Peripheral Spondyloarthritis?
por: Rosine, Nicolas, et al.
Publicado: (2021)

Prevalence of axial spondyloarthritis in patients with acute anterior uveitis: a cross-sectional study utilising MRI
por: Sykes, Mark P, et al.
Publicado: (2018)

Certolizumab Pegol Treatment in Patients with Axial-Spondyloarthritis-Associated Acute Anterior Uveitis: a Narrative Review
por: van der Horst-Bruinsma, Irene E., et al.
Publicado: (2022)

Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis
por: Ceribelli, Angela, et al.
Publicado: (2021)

Neutralization of IL-17 ameliorates uveitis but damages photoreceptors in a murine model of spondyloarthritis
por: Kezic, Jelena M, et al.
Publicado: (2012)

Diagnostic value of anti-Kaiso autoantibody in axial spondyloarthritis
por: Feng, Xinzhe, et al.
Publicado: (2023)

Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? a multicentre retrospective observational study
por: Lekpa, Fernando Kemta, et al.
Publicado: (2012)

Uveitis in spondyloarthritis
por: Rademacher, Judith, et al.
Publicado: (2020)

The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies
por: McGonagle, Dennis G, et al.
Publicado: (2019)

Observed Incidence of Uveitis Following Certolizumab Pegol Treatment in Patients With Axial Spondyloarthritis
por: Rudwaleit, M., et al.
Publicado: (2016)

Enhanced NETosis generation in radiographic axial spondyloarthritis: utility as biomarker for disease activity and anti-TNF-α therapy effectiveness
por: Ruiz-Limon, Patricia, et al.
Publicado: (2020)

VDR Polymorphic Variants Are Related to Improvements in CRP and Disease Activity in Patients with Axial Spondyloarthritis That Undergo Anti-TNF Treatment
por: Bugaj, Bartosz, et al.
Publicado: (2022)

Acute anterior uveitis and other extra-articular manifestations of spondyloarthritis
por: Mitulescu, TC, et al.
Publicado: (2015)

The Management of Acute Anterior Uveitis Complicating Spondyloarthritis: Present and Future
por: Biggioggero, Martina, et al.
Publicado: (2018)

Immunomodulation with IL-17 and TNF-α in spondyloarthritis: focus on the eye and the central nervous system
por: How Shing Koy, Elsa, et al.
Publicado: (2021)

Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease
por: Sugita, Sunao, et al.
Publicado: (2012)

Disease activity in axial spondyloarthritis after discontinuation of TNF inhibitors therapy
por: Sebastian, Agata, et al.
Publicado: (2017)

Comorbidity and response to TNF inhibitors in axial spondyloarthritis: longitudinal analysis of the BSRBR-AS
por: Zhao, Sizheng Steven, et al.
Publicado: (2020)

Predicting response to anti-TNFα therapy among patients with axial spondyloarthritis (axSpA): results from BSRBR-AS
por: Macfarlane, Gary J, et al.
Publicado: (2020)

Cardiovascular risk in patients with spondyloarthritis and association with anti-TNF drugs
por: Chan, Shirley Chiu Wai, et al.
Publicado: (2021)

Spondyloarthritis, Acute Anterior Uveitis, and Fungi: Updating the Catterall–King Hypothesis
por: Laurence, Martin, et al.
Publicado: (2018)

IL-17 in spondyloarthritis: is the T-party over?
por: Yeremenko, Nataliya, et al.
Publicado: (2011)

Juvenile Spondyloarthritis: focus on uveitis
por: Marino, Achille, et al.
Publicado: (2020)

The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEW
por: van der Horst-Bruinsma, Irene, et al.
Publicado: (2020)

The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients
por: Plasencia, Chamaida, et al.
Publicado: (2013)

Anti-TNF therapy for juvenile idiopathic arthritis-related uveitis
por: Semeraro, Francesco, et al.
Publicado: (2014)

Etanercept in axial spondyloarthritis
por: Luo, Gui, et al.
Publicado: (2022)

Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis
por: Gratacós, Jordi, et al.
Publicado: (2019)

Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis: is the reason to switch relevant?
por: Manica, Santiago Rodrigues, et al.
Publicado: (2020)

The Nonradiographic Axial Spondyloarthritis, the Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis: The Tangled Skein of Rheumatology
por: Malaviya, Anand N., et al.
Publicado: (2017)

The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis
por: Tsukazaki, Hiroyuki, et al.
Publicado: (2020)

Younger age of onset and uveitis associated with HLA-B27 and delayed diagnosis in Thai patients with axial spondyloarthritis
por: Limsakul, Naphruet, et al.
Publicado: (2021)

Onset of lupus like syndrome in patients with spondyloarthritis treated with anti-TNF-α
por: Puertas-Abreu, Eduardo, et al.
Publicado: (2012)

Anti-tumour necrosis factor (anti-TNF) in the treatment of juvenile idiopathic arthritis-associated uveitis
por: Rivarola, C, et al.
Publicado: (2008)

Dual Blockade of TNF and IL-17A Inhibits Inflammation and Structural Damage in a Rat Model of Spondyloarthritis
por: Hammoura, Ihsan, et al.
Publicado: (2022)

Serum granulocyte-macrophage colony-stimulating factor (GM-CSF) is increased in patients with active radiographic axial spondyloarthritis and persists despite anti-TNF treatment
por: Papagoras, Charalampos, et al.
Publicado: (2022)

Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial
por: Wei, James Cheng-Chung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u0f3r1t40m91mf8996rh8pu5gs